Jos Perriëns

2.2k total citations · 2 hit papers
21 papers, 1.7k citations indexed

About

Jos Perriëns is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Jos Perriëns has authored 21 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Epidemiology and 5 papers in Virology. Recurrent topics in Jos Perriëns's work include HIV/AIDS Research and Interventions (13 papers), HIV Research and Treatment (5 papers) and HIV, Drug Use, Sexual Risk (5 papers). Jos Perriëns is often cited by papers focused on HIV/AIDS Research and Interventions (13 papers), HIV Research and Treatment (5 papers) and HIV, Drug Use, Sexual Risk (5 papers). Jos Perriëns collaborates with scholars based in Switzerland, United States and Belgium. Jos Perriëns's co-authors include Marie Laga, Lut Van Damme, Gita Ramjee, Helen Rees, Pachara Sirivongrangson, Verapol Chandeying, Marco Vitória, Teguest Guerma, Yves Souteyrand and Charles F. Gilks and has published in prestigious journals such as The Lancet, Nature Medicine and The Journal of Infectious Diseases.

In The Last Decade

Jos Perriëns

21 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial

2002 632 citations Lut Van Damme, Gita Ramjee et al. The Lancet profile →
The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings

2006 510 citations Charles F. Gilks, Siobhan Crowley et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jos Perriëns Switzerland	14	1.0k	529	526	459	325	21	1.7k
Jackoniah O. Ndinya‐Achola Kenya	25	1.1k 1.1×	545 1.0×	756 1.4×	547 1.2×	574 1.8×	48	2.1k
Virginie Ettiègne-Traoré United States	15	897 0.9×	389 0.7×	583 1.1×	669 1.5×	474 1.5×	25	1.6k
L. A. R. Mtimavalye United States	18	1.1k 1.0×	468 0.9×	876 1.7×	666 1.5×	687 2.1×	33	2.2k
Jessica Nakiyingi Uganda	22	1.3k 1.3×	437 0.8×	1.1k 2.1×	158 0.3×	437 1.3×	30	2.3k
Fred Mhalu Tanzania	29	1.6k 1.5×	778 1.5×	892 1.7×	166 0.4×	644 2.0×	103	2.6k
Joelle Brown United States	24	783 0.8×	336 0.6×	652 1.2×	494 1.1×	563 1.7×	51	1.8k
Véronique Batter United States	12	771 0.7×	215 0.4×	620 1.2×	701 1.5×	649 2.0×	17	1.6k
Rachel A. Royce United States	24	1.6k 1.5×	844 1.6×	1.2k 2.3×	708 1.5×	734 2.3×	41	3.0k
Mamadou O. Diallo United States	18	745 0.7×	281 0.5×	587 1.1×	360 0.8×	338 1.0×	29	1.3k
Anthony Mwatha United States	25	2.0k 1.9×	1.1k 2.1×	955 1.8×	216 0.5×	595 1.8×	51	2.6k

Countries citing papers authored by Jos Perriëns

Since Specialization

Citations

This map shows the geographic impact of Jos Perriëns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jos Perriëns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jos Perriëns more than expected).

Fields of papers citing papers by Jos Perriëns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jos Perriëns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jos Perriëns. The network helps show where Jos Perriëns may publish in the future.

Co-authorship network of co-authors of Jos Perriëns

This figure shows the co-authorship network connecting the top 25 collaborators of Jos Perriëns. A scholar is included among the top collaborators of Jos Perriëns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jos Perriëns. Jos Perriëns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Holmes, Charles B., Albert Mwango, Jos Perriëns, et al.. (2014). Health systems implications of the 2013 WHO consolidated antiretroviral guidelines and strategies for successful implementation. AIDS. 28. S231–S239. 10 indexed citations

Granich, Reuben, Ying-Ru Lo, Amitabh B. Suthar, et al.. (2011). Harnessing the Prevention Benefits of Antiretroviral Therapy to Address HIV and Tuberculosis. Current HIV Research. 9(6). 355–366. 5 indexed citations

Schwartländer, Bernhard, et al.. (2006). The 10-year struggle to provide antiretroviral treatment to people with HIV in the developing world. The Lancet. 368(9534). 541–546. 55 indexed citations

Gilks, Charles F., Siobhan Crowley, René Ekpini, et al.. (2006). The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. The Lancet. 368(9534). 505–510. 510 indexed citations breakdown →

Lange, Joep M. A., et al.. (2004). What policymakers should know about drug resistance and adherence in the context of scaling-up treatment of HIV infection. AIDS. 18(Supplement 3). S69–S74. 29 indexed citations

Pontali, Emanuele, et al.. (2003). Antiretroviral Treatment in Resource-limited Settings. Journal of Health Management. 5(2). 315–326. 1 indexed citations

Damme, Lut Van, Gita Ramjee, Michel Alary, et al.. (2002). Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. The Lancet. 360(9338). 971–977. 632 indexed citations breakdown →

Hammer, Scott M., et al.. (2002). Antiretroviral guidelines for resource-limited settings: The WHO's public health approach. Nature Medicine. 8(7). 649–650. 11 indexed citations

Damme, Lut Van, Verapol Chandeying, Gita Ramjee, et al.. (2000). Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. AIDS. 14(1). 85–88. 79 indexed citations

10.

Tyndall, Mark, Shaheed Vally Omar, Kelly S. MacDonald, et al.. (1999). A Randomized, Double‐Blind, Placebo‐Controlled Trial of Single‐Dose Ciprofloxacin versus Erythromycin for the Treatment of Chancroid in Nairobi, Kenya. The Journal of Infectious Diseases. 180(6). 1886–1893. 29 indexed citations

11.

Perriëns, Jos, et al.. (1999). A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancr. 1 indexed citations

12.

Katabira, Elly, Nelson K. Sewankambo, Roy D. Mugerwa, et al.. (1998). Lack of efficacy of low dose oral interferon alfa in symptomatic HIV-1 infection: a randomised, double blind, placebo controlled trial.. Sexually Transmitted Infections. 74(4). 265–270. 14 indexed citations

13.

Goeman, Jelle J., Ibra Ndoye, Souleymane Mboup, et al.. (1995). Frequent Use of Menfegol Spermicidal Vaginal Foaming Tablets Associated with a High Incidence of Genital Lesions. The Journal of Infectious Diseases. 171(6). 1611–1614. 16 indexed citations

14.

Mukadi, Ya Diul, Jos Perriëns, Michael E. St. Louis, et al.. (1993). Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. The Lancet. 342(8864). 143–146. 99 indexed citations

15.

Thea, Donald M., Roger I. Glass, Gary Grohmann, et al.. (1993). Prevalence of enteric viruses among hospital patients with AIDS in Kinshasa, Zaire. Transactions of the Royal Society of Tropical Medicine and Hygiene. 87(3). 263–266. 25 indexed citations

16.

Perriëns, Jos, et al.. (1992). Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients.. PubMed. 72(1). 45–52. 37 indexed citations

17.

Perriëns, Jos, et al.. (1992). High-Dose Cyclophosphamide and Dexamethasone in Paraquat Poisoning: A Prospective Study. Human & Experimental Toxicology. 11(2). 129–134. 46 indexed citations

18.

Hassig, Susan E., et al.. (1990). An analysis of the economic impact of HIV infection among patients at Mama Yemo Hospital, Kinshasa, Zaire. AIDS. 4(9). 883–888. 27 indexed citations

19.

Colebunders, Robert, R. W. Ryder, Jos Perriëns, et al.. (1990). Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, Zaire. Journal of Infection. 21(2). 167–173. 63 indexed citations

20.

Perriëns, Jos, et al.. (1988). Clinical manifestations and management of adults with HIV infection. 3(1). 51–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact